here we go again.

Forbes, Lipinski Reintroduce Bipartisan Bill to Accelerate Promising Stem Cell Research, Avoid Divisive Political Battles

Washington, D.C., Sep 20 -
Congressman J. Randy Forbes (VA-04) announced today that he and Democratic Congressman Dan Lipinski (IL-03) have reintroduced the bipartisan Patients First Act, H.R. 2951, a bill to intensify research and human clinical trials using stem cells that are ethically obtained and that show evidence of providing near-term clinical benefit for human patients. The Patients First Act prioritizes funding for promising stem cell research and would not authorize any new spending. Additionally, the legislation would promote the creation of pluripotent stem cell lines without the creation, destruction, or discarding of human embryos.

"The promise of stem cell research provides Americans with both new hopes and fears. As public servants, we have the responsibility to consider both the medical and the ethical implications of the research we support with U.S. tax-dollars, particularly at a time of budgetary constraints. The Patients First Act recognizes that the twin goals of scientific advancement and the protection of human life are not mutually exclusive; rather, they should be one in the same. By setting aside divisive political battles and prioritizing research with proven clinical success, we can finally make long-awaited progress in beating dreaded diseases, from diabetes to breast cancer" said Forbes.